跳至主要内容
临床试验/ISRCTN72853206
ISRCTN72853206已完成未知

Intra-coronary transfusion of autologous CD34+ cells improves left ventricular function in patients with diffuse coronary artery disease and non candidates for coronary artery intervention: a randomised controlled trial

ational Science Council (Taiwan)0 个研究点目标入组 38 人开始时间: 2012年2月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
38

研究概览

简要总结

2015 results in https://pubmed.ncbi.nlm.nih.gov/26154930/ (added 17/12/2020) 2020 results in https://pubmed.ncbi.nlm.nih.gov/32727585/ (added 17/12/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients aged 20-80
  • 2. Have angina pectoris resulted in severely and diffusely atherosclerotic-obstructive CAD with refractory to optimal medication not the candidates for both PCI or CABG

排除标准

  • 1. Age <20 years or > 80 years
  • 2. Pregnant women
  • 3. Patients with adventitious agents [like:Human immunodeficiency virus (HIV), Hepatitis viruses]
  • 4. Recent myocardial infarction (MI) within 3 months
  • 5. Aortic stenosis or mitral stenosis
  • 6. Congestive heart failure
  • 7. New York Heart Association Functional Class IV (NYHA Fc.IV)
  • 8. Malignancy or other severe disease with life span less than one year
  • 9. Chronic kidney disease with creatinine clearance (CCr) <20ml/min and end stage renal disease

研究者

发起方
ational Science Council (Taiwan)

相似试验